MiMedx Group Financials - Benzinga

MiMedx Group Inc

MDXGNASDAQ

Trade with Public

Trade with Public

$4.34

0.163.83%

At close: Aug 7, 5:00 PM EST

$4.34

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

MiMedx Group Financials

MiMedx Group (MDXG) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
MiMedx Group Affirms FY2026 Sales Guidance of $260.000M-$290.000M vs $269.440M Est

MiMedx Group (NASDAQ:MDXG) affirms FY2026 sales outlook from $260.000 million-$290.000 million to $260.000 million-$290.000 million vs $269.440 million estimate.

Benzinga Newsdesk

PRO
MiMedx Group Q2 Adj. EPS $(0.05), Inline, Sales $64.362M Beat $63.460M Estimate

MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 150 percent decrease over earnings of $0.10 per share from the same period last year. The

Benzinga Newsdesk

PRO
CORRECTION: MiMedx Group Q1 Adj. EPS $(0.05) Misses $(0.03) Estimate, Sales $58.991M Miss $65.020M Estimate.

MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 183.33 percent decrease over earnings of $0.06 per share from

Benzinga Newsdesk

PRO
MiMedx Group Lowers FY2026 Sales Guidance from $340.000M-$360.000M to $260.000M-$290.000M vs $307.000M Est

MiMedx Group (NASDAQ:MDXG) lowers FY2026 sales outlook from $340.000 million-$360.000 million to $260.000 million-$290.000 million vs $307.000 million estimate.

Benzinga Newsdesk

Earnings Scheduled For April 29, 2026

Benzinga Insights

PRO
MiMedx Group Sees FY2026 Sales $340.000M-$360.000M vs $376.533M Est

MiMedx Group (NASDAQ:MDXG) sees FY2026 sales of $340.000 million-$360.000 million vs $376.533 million analyst estimate.

Benzinga Newsdesk